Better, shorter combination treatment for people with visceral leishmaniasis shown to be effective in Eastern Africa

New results from a study by DNDi and partners show that the combination treatment miltefosine and paromomycin is over 91% effective in treating visceral leishmaniasis in Eastern Africa. Children – who are the majority of visceral leishmaniasis patients – also responded well to this new treatment.